astraveus
astraveus.com
Actively hiring
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$17.8M
1 round on record
Latest round
$17.8M
Seed · Jun 2023 · 3 yr ago
Team
20–49
French register · Dec 2023
Backers
1
M Ventures
The money's age
Long since its last round
39 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 21, 2024
Increased its share capital $1M · BODACC
Jun 27, 2023
Raised a round Seed $17.8M · PRNewswire
Oct 21, 2022
Increased its share capital $829k · BODACC
Sep 30, 2021
Increased its share capital $478k · BODACC
Oct 28, 2018
Increased its share capital $108k · BODACC
Feb 22, 2018
Renamed Astraveus · BODACC
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Jun 2023 | $17.8M | — | PRNewswire |
Registers and programsofficial lists and records that name the company
| Legal entity | ASTRAVEUS SAS | its site |
| Registered | 5 Jul 2016 |
Founders and leadersfrom filings, registers and the company's site
Jérémie LaurentPrésident de SAScompany register
Backed byfrom the funds' portfolios and accelerator catalogs
M Ventures Similar startupsby what they do, their industry and backers
We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
About Us Cell Therapies for Life-Threatening Diseases LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's…
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Building the next generation of cell therapies. Cell therapies face key challenges that limit their efficacy and accessibility:.
Designer cell therapies for pets first and their people next.
News
Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory
/PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), the Benchtop Cell Factory company, today announces that it has further strengthened its world...
Read more
Report
Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory
Highly experienced hires bring robust operational and technical expertise Momentum builds at Astraveus following exceptional additions of Jean-Paul Mangeolle, David Newble, and Laurence Riot Lamotte earlier this year Paris, France, 21 October 2025 - Astra
Read more
Report
Download Presentation: ATE2025 Barcelona, September 2025
Your registration could not be saved. Please try again. Your registration was successful. I hereby agree to receive email communications from Astraveus. I understand that my information will be used in accordance with the Privacy Policy, and that I may wi
Read more
Report
Orange County Bio: Astraveus "Bringing Cell Therapies Closer to Patients"
The interview in Orange County Bio describes how Astraveus's Lakhesys Benchtop Cell Factory uses microfluidics, automation, and miniaturization to reduce CAR-T therapy cost, shorten vein-to-vein time, and enable decentralized manufacturing.
Read more
Report
Innovations.fr on Astraveus Revolutionizing Cell Therapy
Innovations.fr profiles Astraveus's table-top microfluidic "mini-factory" poised to produce hundreds of cell-therapy doses per year-slashing costs and footprint.
Read more
Report
Usine Nouvelle on Astraveus Mini-Factory Industrialization
L'Usine Nouvelle's Clara Mathieu details Astraveus's 'Première usine' grant and plans to industrialize its mini cell therapy factory at Kremlin-Bicêtre by late 2025.
Read more
Report
Download Presentation: Astraveus at ISCT, New Orleans, May 2025
Your registration could not be saved. Please try again. Your registration was successful. I hereby agree to receive email communications from Astraveus. I understand that my information will be used in accordance with the Privacy Policy, and that I may wi
Read more
Report
Download Poster: Small is Powerful: Demonstrating the Potential of a Novel Microfluidic Benchtop Cell Factory
Your registration could not be saved. Please try again. Your registration was successful. I hereby agree to receive email communications from Astraveus. I understand that my information will be used in accordance with the Privacy Policy, and that I may wi
Read more
Report
BioProcess Insider on Astraveus & NecstGen CGT Bottlenecks
In BioProcess Insider, Shreeyashi Ojha covers Astraveus and NecstGen's evaluation of the Lakhesys cell factory to tackle CGT bottlenecks in Leiden.
Read more
Report
GEN News: Astraveus & NecstGen CAR-T Partnership
In a GEN News article, Astraveus and NecstGen announce a partnership to evaluate the Lakhesys Benchtop Cell Factory for cost-effective CAR-T manufacturing.
Read more
Report
Show more news
People
Jérémie Laurent
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Le Kremlin-Bicêtre
France
HQ
Contact
10-50 est. staff
Financials
Total raised
$17.8M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2023 | $17.8M | Details |